TY - STD TI - Canadian Hydroxychloroquine Study Group. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med, 1991. 324(3): p. 150–4. ID - ref1 ER - TY - JOUR AU - Clowse, M. E. PY - 2006 DA - 2006// TI - Hydroxychloroquine in lupus pregnancy JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.22159 DO - 10.1002/art.22159 ID - Clowse2006 ER - TY - JOUR AU - Izmirly, P. M. PY - 2010 DA - 2010// TI - Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2009.119263 DO - 10.1136/ard.2009.119263 ID - Izmirly2010 ER - TY - JOUR AU - Izmirly, P. M. PY - 2012 DA - 2012// TI - Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus JO - Circulation VL - 126 UR - https://doi.org/10.1161/CIRCULATIONAHA.111.089268 DO - 10.1161/CIRCULATIONAHA.111.089268 ID - Izmirly2012 ER - TY - JOUR AU - Barsalou, J. PY - 2018 DA - 2018// TI - Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus JO - Ann Rheum Dis VL - 77 UR - https://doi.org/10.1136/annrheumdis-2018-213718 DO - 10.1136/annrheumdis-2018-213718 ID - Barsalou2018 ER - TY - JOUR AU - Izmirly, P. PY - 2020 DA - 2020// TI - Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA/Ro-positive mothers JO - J Am Coll Cardiol VL - 76 UR - https://doi.org/10.1016/j.jacc.2020.05.045 DO - 10.1016/j.jacc.2020.05.045 ID - Izmirly2020 ER - TY - JOUR AU - Molad, Y. PY - 2002 DA - 2002// TI - Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort JO - Lupus VL - 11 UR - https://doi.org/10.1191/0961203302lu203ra DO - 10.1191/0961203302lu203ra ID - Molad2002 ER - TY - JOUR AU - Fessler, B. J. PY - 2005 DA - 2005// TI - Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.21039 DO - 10.1002/art.21039 ID - Fessler2005 ER - TY - JOUR AU - Pons-Estel, G. J. PY - 2009 DA - 2009// TI - Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort JO - Arthritis Rheum VL - 61 UR - https://doi.org/10.1002/art.24538 DO - 10.1002/art.24538 ID - Pons-Estel2009 ER - TY - JOUR AU - Wallace, D. J. PY - 1987 DA - 1987// TI - Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus? JO - Arthritis Rheum VL - 30 UR - https://doi.org/10.1002/art.1780301219 DO - 10.1002/art.1780301219 ID - Wallace1987 ER - TY - JOUR AU - Petri, M. PY - 1996 DA - 1996// TI - Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective JO - Scand J Rheumatol VL - 25 UR - https://doi.org/10.3109/03009749609069986 DO - 10.3109/03009749609069986 ID - Petri1996 ER - TY - JOUR AU - Erkan, D. PY - 2002 DA - 2002// TI - A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome JO - Rheumatology (Oxford) VL - 41 UR - https://doi.org/10.1093/rheumatology/41.8.924 DO - 10.1093/rheumatology/41.8.924 ID - Erkan2002 ER - TY - JOUR AU - Ho, K. T. PY - 2005 DA - 2005// TI - Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events JO - Rheumatology (Oxford) VL - 44 UR - https://doi.org/10.1093/rheumatology/kei014 DO - 10.1093/rheumatology/kei014 ID - Ho2005 ER - TY - JOUR AU - Ruiz-Irastorza, G. PY - 2006 DA - 2006// TI - Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus JO - Lupus VL - 15 UR - https://doi.org/10.1177/0961203306071872 DO - 10.1177/0961203306071872 ID - Ruiz-Irastorza2006 ER - TY - JOUR AU - Tao, C. Y. PY - 2019 DA - 2019// TI - Impact of antimalarial (AM) on serum lipids in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis JO - Medicine (Baltimore) VL - 98 UR - https://doi.org/10.1097/MD.0000000000015030 DO - 10.1097/MD.0000000000015030 ID - Tao2019 ER - TY - JOUR AU - Petri, M. PY - 1994 DA - 1994// TI - Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis JO - Am J Med VL - 96 UR - https://doi.org/10.1016/0002-9343(94)90151-1 DO - 10.1016/0002-9343(94)90151-1 ID - Petri1994 ER - TY - JOUR AU - Petri, M. PY - 1996 DA - 1996// TI - Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis JO - Lupus VL - 5 UR - https://doi.org/10.1177/0961203396005001051 DO - 10.1177/0961203396005001051 ID - Petri1996 ER - TY - JOUR AU - Mok, C. C. AU - Mak, A. AU - Ma, K. M. PY - 2005 DA - 2005// TI - Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus JO - Lupus VL - 14 UR - https://doi.org/10.1191/0961203305lu2039oa DO - 10.1191/0961203305lu2039oa ID - Mok2005 ER - TY - JOUR AU - Alarcon, G. S. PY - 2007 DA - 2007// TI - Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L) JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2006.068676 DO - 10.1136/ard.2006.068676 ID - Alarcon2007 ER - TY - JOUR AU - Shinjo, S. K. PY - 2010 DA - 2010// TI - Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort JO - Arthritis Rheum VL - 62 UR - https://doi.org/10.1002/art.27300 DO - 10.1002/art.27300 ID - Shinjo2010 ER - TY - JOUR AU - Ruiz-Irastorza, G. PY - 2010 DA - 2010// TI - Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2008.101766 DO - 10.1136/ard.2008.101766 ID - Ruiz-Irastorza2010 ER - TY - JOUR AU - Mackenzie, A. H. PY - 1983 DA - 1983// TI - Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials JO - Am J Med VL - 75 UR - https://doi.org/10.1016/0002-9343(83)91269-X DO - 10.1016/0002-9343(83)91269-X ID - Mackenzie1983 ER - TY - JOUR AU - Mavrikakis, I. PY - 2003 DA - 2003// TI - The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal JO - Ophthalmology VL - 110 UR - https://doi.org/10.1016/S0161-6420(03)00409-3 DO - 10.1016/S0161-6420(03)00409-3 ID - Mavrikakis2003 ER - TY - JOUR AU - Wolfe, F. AU - Marmor, M. F. PY - 2010 DA - 2010// TI - Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus JO - Arthritis Care Res (Hoboken) VL - 62 UR - https://doi.org/10.1002/acr.20133 DO - 10.1002/acr.20133 ID - Wolfe2010 ER - TY - JOUR AU - Melles, R. B. AU - Marmor, M. F. PY - 2014 DA - 2014// TI - The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy JO - JAMA Ophthalmol VL - 132 UR - https://doi.org/10.1001/jamaophthalmol.2014.3459 DO - 10.1001/jamaophthalmol.2014.3459 ID - Melles2014 ER - TY - JOUR AU - Chatre, C. PY - 2018 DA - 2018// TI - Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature JO - Drug Saf VL - 41 UR - https://doi.org/10.1007/s40264-018-0689-4 DO - 10.1007/s40264-018-0689-4 ID - Chatre2018 ER - TY - JOUR AU - Nord, J. E. PY - 2004 DA - 2004// TI - Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature JO - Semin Arthritis Rheum VL - 33 UR - https://doi.org/10.1016/j.semarthrit.2003.09.012 DO - 10.1016/j.semarthrit.2003.09.012 ID - Nord2004 ER - TY - JOUR AU - Joyce, E. AU - Fabre, A. AU - Mahon, N. PY - 2013 DA - 2013// TI - Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review JO - Eur Heart J Acute Cardiovasc Care VL - 2 UR - https://doi.org/10.1177/2048872612471215 DO - 10.1177/2048872612471215 ID - Joyce2013 ER - TY - JOUR AU - Yogasundaram, H. PY - 2014 DA - 2014// TI - Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment JO - Can J Cardiol VL - 30 UR - https://doi.org/10.1016/j.cjca.2014.08.016 DO - 10.1016/j.cjca.2014.08.016 ID - Yogasundaram2014 ER - TY - JOUR AU - Izmirly, P. M. PY - 2017 DA - 2017// TI - The incidence and prevalence of systemic lupus erythematosus in New York County (Manhattan), New York: the Manhattan lupus surveillance program JO - Arthritis Rheumatol VL - 69 UR - https://doi.org/10.1002/art.40192 DO - 10.1002/art.40192 ID - Izmirly2017 ER - TY - JOUR AU - Dall'Era, M. PY - 2017 DA - 2017// TI - The incidence and prevalence of systemic lupus erythematosus in San Francisco County, California: the California lupus surveillance project JO - Arthritis Rheumatol VL - 69 UR - https://doi.org/10.1002/art.40191 DO - 10.1002/art.40191 ID - Dall'Era2017 ER - TY - JOUR AU - Ferucci, E. D. PY - 2014 DA - 2014// TI - Prevalence and incidence of systemic lupus erythematosus in a population-based registry of American Indian and Alaska Native people, 2007-2009 JO - Arthritis Rheumatol VL - 66 UR - https://doi.org/10.1002/art.38720 DO - 10.1002/art.38720 ID - Ferucci2014 ER - TY - JOUR AU - Lim, S. S. PY - 2014 DA - 2014// TI - The incidence and prevalence of systemic lupus erythematosus, 2002-2004: the Georgia Lupus Registry JO - Arthritis Rheumatol VL - 66 UR - https://doi.org/10.1002/art.38239 DO - 10.1002/art.38239 ID - Lim2014 ER - TY - JOUR AU - Somers, E. C. PY - 2014 DA - 2014// TI - Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program JO - Arthritis Rheumatol VL - 66 UR - https://doi.org/10.1002/art.38238 DO - 10.1002/art.38238 ID - Somers2014 ER - TY - JOUR AU - Hochberg, M. C. PY - 1997 DA - 1997// TI - Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus JO - Arthritis Rheum VL - 40 UR - https://doi.org/10.1002/art.1780400928 DO - 10.1002/art.1780400928 ID - Hochberg1997 ER - TY - JOUR AU - Petri, M. PY - 2012 DA - 2012// TI - Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus JO - Arthritis Rheum VL - 64 UR - https://doi.org/10.1002/art.34473 DO - 10.1002/art.34473 ID - Petri2012 ER - TY - JOUR AU - Petri, M. PY - 2005 DA - 2005// TI - Combined oral contraceptives in women with systemic lupus erythematosus JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa051135 DO - 10.1056/NEJMoa051135 ID - Petri2005 ER - TY - JOUR AU - Petri, M. A. PY - 2013 DA - 2013// TI - FRI0293 Validation of the revised SELENA flare index in systemic lupus erythematosus JO - Ann Rheum Dis VL - 72 UR - https://doi.org/10.1136/annrheumdis-2013-eular.1420 DO - 10.1136/annrheumdis-2013-eular.1420 ID - Petri2013 ER - TY - JOUR AU - Urowitz, M. B. PY - 2006 DA - 2006// TI - The effect of menopause on disease activity in systemic lupus erythematosus JO - J Rheumatol VL - 33 ID - Urowitz2006 ER - TY - JOUR AU - Marmor, M. F. PY - 2016 DA - 2016// TI - Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision) JO - Ophthalmology VL - 123 UR - https://doi.org/10.1016/j.ophtha.2016.01.058 DO - 10.1016/j.ophtha.2016.01.058 ID - Marmor2016 ER - TY - JOUR AU - Marmor, M. F. PY - 2011 DA - 2011// TI - Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy JO - Ophthalmology VL - 118 UR - https://doi.org/10.1016/j.ophtha.2010.11.017 DO - 10.1016/j.ophtha.2010.11.017 ID - Marmor2011 ER - TY - JOUR AU - Browning, D. J. PY - 2016 DA - 2016// TI - The prevalence of hydroxychloroquine retinopathy and toxic dosing, and the role of the ophthalmologist in reducing both JO - Am J Ophthalmol VL - 166 UR - https://doi.org/10.1016/j.ajo.2016.03.044 DO - 10.1016/j.ajo.2016.03.044 ID - Browning2016 ER - TY - JOUR AU - Jallouli, M. PY - 2015 DA - 2015// TI - Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus JO - Arthritis Rheumatol VL - 67 UR - https://doi.org/10.1002/art.39194 DO - 10.1002/art.39194 ID - Jallouli2015 ER - TY - JOUR AU - Kalia, S. AU - Dutz, J. P. PY - 2007 DA - 2007// TI - New concepts in antimalarial use and mode of action in dermatology JO - Dermatol Ther VL - 20 UR - https://doi.org/10.1111/j.1529-8019.2007.00131.x DO - 10.1111/j.1529-8019.2007.00131.x ID - Kalia2007 ER - TY - JOUR AU - Chen, S. K. PY - 2019 DA - 2019// TI - Lipid testing and statin prescriptions among Medicaid recipients with systemic lupus erythematosus or diabetes mellitus and the general Medicaid population JO - Arthritis Care Res (Hoboken) VL - 71 UR - https://doi.org/10.1002/acr.23574 DO - 10.1002/acr.23574 ID - Chen2019 ER - TY - JOUR AU - Petri, M. A. PY - 2011 DA - 2011// TI - Lupus atherosclerosis prevention study (LAPS) JO - Ann Rheum Dis VL - 70 UR - https://doi.org/10.1136/ard.2010.136762 DO - 10.1136/ard.2010.136762 ID - Petri2011 ER - TY - JOUR AU - Schanberg, L. E. PY - 2012 DA - 2012// TI - Use of atorvastatin in systemic lupus erythematosus in children and adolescents JO - Arthritis Rheum VL - 64 UR - https://doi.org/10.1002/art.30645 DO - 10.1002/art.30645 ID - Schanberg2012 ER - TY - JOUR AU - Ardoin, S. P. PY - 2014 DA - 2014// TI - Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2012-202315 DO - 10.1136/annrheumdis-2012-202315 ID - Ardoin2014 ER - TY - JOUR AU - Willis, R. PY - 2014 DA - 2014// TI - Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: data from LUMINA (LXXVI), a multi-ethnic US cohort JO - Clin Exp Rheumatol VL - 32 ID - Willis2014 ER - TY - JOUR AU - Amuro, H. PY - 2010 DA - 2010// TI - Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production JO - Arthritis Rheum VL - 62 ID - Amuro2010 ER - TY - JOUR AU - Erkan, D. PY - 2014 DA - 2014// TI - A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-203622 DO - 10.1136/annrheumdis-2013-203622 ID - Erkan2014 ER -